# Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus.

> **NCT05262257** · EARLY_PHASE1 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 120 (estimated)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DRUG:** Metformin
- **DRUG:** Dapagliflozin
- **BEHAVIORAL:** Lifestyle intervention

## Key facts

- **NCT ID:** NCT05262257
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05262257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05262257, "Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05262257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*